CLDI
Calidi Biotherapeutics Inc
Calidi Biotherapeutics Inc 13F Holders
CLDI Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $157.12
- Current price*:
- -99.13%($1.36)
1 value investing guru has made changes to the Calidi Biotherapeutics Inc (CLDI) position according to the gurus' 2021 Q4 SEC quarterly report(s). CLDI has been bought (as a new position) by 1 guru(s)
Which gurus or hedge funds bought CLDI in 2021 Q4?
According to the 2021 Q4 SEC filing(s) Calidi Biotherapeutics Inc (CLDI) has been bought by Howard Marks - Oaktree Capital Management (new buy).
To see more about who is investing in Calidi Biotherapeutics Inc (CLDI), please go to the CLDI ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".